MARCIE KABLE: Open Payments
NPI 1750645644 · SAGINAW, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$676 in 23 payments from 14 companies in 2025. Trend: 2023 $380 · 2024 $285 · 2025 $676
Food & beverage: $676
| Company | Payments | Amount |
|---|---|---|
| Recor Medical Inc | 2 | $115 |
| Kestra Medical Technology Services, Inc. | 4 | $104 |
| Novo Nordisk Inc | 1 | $103 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $85 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 2 | $44 |
| ABIOMED | 1 | $39 |
| SCPHARMACEUTICALS INC. | 2 | $35 |
| E.R. Squibb & Sons, L.L.C. | 2 | $34 |
| Novartis Pharmaceuticals Corporation | 1 | $22 |
| BridgeBio Pharma, Inc. | 1 | $21 |
Products named: Paradise Ultrasound Renal Denervation System, Assure WCD, Wegovy, Kerendia, LifeVest, FUROSCIX, CAMZYOS, LEQVIO.
Industry payments across MI — which companies pay providers there.
